6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Chronic Pain and Opioid Addiction Management
Chronic pain management often involves opioids, which carry a high risk of addiction. Prolonged use can lead to tolerance, dependence, and misuse, complicating pain relief efforts. A comprehensive approach to managing this dual challenge includes multimodal therapies such as physical rehabilitation, cognitive-behavioral therapy, and non-opioid analgesics like NSAIDs and antidepressants. Emerging treatments like medical cannabis and neuromodulation techniques offer promising alternatives. Integrated care models, combining addiction treatment with pain management, are critical. Medication-assisted therapy (MAT) using buprenorphine or methadone helps stabilize opioid dependence while addressing pain. Patient education and regular monitoring reduce misuse risks, fostering sustainable recovery and improved quality of life.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States